
Biomark Diagnostics
An oncology-focused company with advanced near-to- market diagnostic technologies designed to improve patient outcomes.
Market cap
$24.7m
Enterprise value
$23m
Share price
CAD0.34 BUX.CN
Authorizing premium user...
An oncology-focused company with advanced near-to- market diagnostic technologies designed to improve patient outcomes.